Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01356
|
|||||
| Drug Name |
Fenoterol
|
|||||
| Synonyms |
Berotec; Berotek; Fenoterolum; Phenoterol; TH 1165A; Berotec (TN); Fenoterolum [INN-Latin]; P-Hydroxyphenylorciprenaline; Th-1165a; Fenoterol (USAN/INN); Fenoterol [USAN:BAN:INN]; P-Hydroxyphenyl-orciprenaline; 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane; 1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane; 3,5-Dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol; 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol; 5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)benzene-1,3-diol; 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol; 5-{1-Hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Bronchospasm [ICD11: CB40.Y] | Approved | [1] | |||
| Therapeutic Class |
Bronchodilator Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H21NO4
|
|||||
| Canonical SMILES |
CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O
|
|||||
| InChI |
InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3
|
|||||
| InChIKey |
LSLYOANBFKQKPT-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 13392-18-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 303.35 | Topological Polar Surface Area | 93 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
3139843
, 5309237
, 8152125
, 11335580
, 11360819
, 11364140
, 11366702
, 11369264
, 11371989
, 11374645
, 11377426
, 11461791
, 11466310
, 11467430
, 11485112
, 11486139
, 11489204
, 11490730
, 11492828
, 11495060
, 14898535
, 29222478
, 46509099
, 47206103
, 47291071
, 47588932
, 47736409
, 48035038
, 48184935
, 48334419
, 48334420
, 48416005
, 49698910
, 49892796
, 50111072
, 50399113
, 53787631
, 57321740
, 85209078
, 85348787
, 85788457
, 90340690
, 92712692
, 103209027
, 103850832
, 104022469
, 104094325
, 104303233
, 117616342
, 124749797
|
|||||
| ChEBI ID |
CHEBI:149226
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | National Center for Advancing Translational Science-Inxight: drug (22M9P70OQ9) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.